2022
Evaluation and Management of the Patient with a Pancreatic Cyst
Göktürk S, Muniraj T, Aslanian H. Evaluation and Management of the Patient with a Pancreatic Cyst. 2022, 415-430. DOI: 10.1007/978-3-030-41683-6_27.Peer-Reviewed Original Research
2021
Evaluation and Management of the Patient with a Pancreatic Cyst
Göktürk S, Muniraj T, Aslanian H. Evaluation and Management of the Patient with a Pancreatic Cyst. 2021, 1-16. DOI: 10.1007/978-3-030-37482-2_27-1.Peer-Reviewed Original Research
2020
Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance
Chhoda A, Yousaf MN, Madhani K, Aslanian H, Jamidar PA, Suarez AL, Salem R, Muniraj T, Kunstman J, Farrell JJ. Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance. Clinical Gastroenterology And Hepatology 2020, 20: 631-640.e1. PMID: 33309984, DOI: 10.1016/j.cgh.2020.12.008.Peer-Reviewed Original ResearchConceptsCharlson Comorbidity IndexHigh-risk stigmataMucinous pancreatic cystsOverall mortalityWorrisome featuresPancreatic cystsComorbidity burdenAge-adjusted Charlson comorbidity indexKaplan-Meir survival analysisLow-risk cystsSingle-center studyHigher overall mortalityElectronic medical recordsComorbidity indexProspective surveillanceCenter studyMortality outcomesMedical recordsMucinous cystsPatient outcomesSerial imagingSurveillance populationCohort stratificationSurvival analysisAbstractTextSimple mucinous cysts of the pancreas have heterogeneous somatic mutations
Attiyeh M, Zhang L, Iacobuzio-Donahue C, Allen P, Imam R, Basturk O, Klimstra D, Sigel C. Simple mucinous cysts of the pancreas have heterogeneous somatic mutations. Human Pathology 2020, 101: 1-9. PMID: 32380013, PMCID: PMC7321854, DOI: 10.1016/j.humpath.2020.04.006.Peer-Reviewed Original ResearchConceptsIntraductal papillary mucinous neoplasmPapillary mucinous neoplasmMucinous neoplasmsMucinous cystsGenomic alterationsSpectrum of genomic alterationsPancreatic intraepithelial neoplasiaHeterogeneous somatic mutationsSimple mucinous cystTargeted sequencing analysisPancreatic cancer genesIntraepithelial neoplasiaMucinous neoplasiaGNAS mutationsNeoplasmsSomatic mutationsEpithelial liningMutated genesCancer genesPreinvasive neoplasmsCystsPancreasNeoplasiaMutationsAlterationsSu1486 LONG-TERM SURVEILLANCE OF LOW-RISK PRESUMED MUCINOUS CYSTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Chhoda A, singh S, Sheth A, Grimshaw A, Farrell J. Su1486 LONG-TERM SURVEILLANCE OF LOW-RISK PRESUMED MUCINOUS CYSTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology 2020, 158: s-599. DOI: 10.1016/s0016-5085(20)32200-9.Peer-Reviewed Original Research
2014
Fine Needle Aspiration Cytology of Acinar Cell Cystadenoma of the Pancreas
Yergiyev O, Krishnamurti U, Mohanty A, Thakkar S, Gurram K, Silverman J. Fine Needle Aspiration Cytology of Acinar Cell Cystadenoma of the Pancreas. Acta Cytologica 2014, 58: 297-302. PMID: 24852936, DOI: 10.1159/000362379.Peer-Reviewed Original ResearchConceptsAcinar cell cystadenomaFine-needle aspirationCystic lesionsCytology specimenIntraductal papillary mucinous neoplasmFine needle aspiration cytologyFirst detailed case reportPapillary mucinous neoplasmEosinophilic amorphous materialPancreatic cystic lesionsNeedle aspiration cytologyDetailed case reportPaucity of literatureSurgical resectionAsymptomatic femalesInitial diagnosisMucinous neoplasmsCase reportCytologic examinationSparse cellularityMucinous cystsDifferential diagnosisNeedle aspirationAspiration cytologyCytomorphologic features
2012
Commercial Molecular Panels Are of Limited Utility in the Classification of Pancreatic Cystic Lesions
Panarelli N, Sela R, Schreiner A, Crapanzano J, Klimstra D, Schnoll-Sussman F, Pochapin M, Yantiss R. Commercial Molecular Panels Are of Limited Utility in the Classification of Pancreatic Cystic Lesions. The American Journal Of Surgical Pathology 2012, 36: 1434-1443. PMID: 22982886, DOI: 10.1097/pas.0b013e31825d534a.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAllelic ImbalanceBiomarkers, TumorCystadenoma, SerousDiagnosis, DifferentialDNA, NeoplasmEndoscopic Ultrasound-Guided Fine Needle AspirationFemaleHumansMaleMicrosatellite RepeatsMiddle AgedMucinsNeuroendocrine TumorsPancreatic CystPancreatic NeoplasmsPancreatic PseudocystProspective StudiesProto-Oncogene ProteinsProto-Oncogene Proteins p21(ras)ras ProteinsConceptsLow-grade dysplasiaPancreatic cystic lesionsMucinous cystsCystic lesionsClassification of pancreatic cystic lesionsSmall pancreatic cystic lesionsFine-needle aspiration biopsyEvaluation of pancreatic cystsHigh-grade dysplasiaMucinous cystic neoplasmsClassification of pancreatic lesionsCytologic aspiratesIntermediate-gradeSurgical resectionSerous cystadenomaSeven cystsAspiration biopsyMucinous neoplasmsCystic neoplasmsClinical featuresPancreatic lesionsPancreatic cystsMolecular panelRadiographic criteriaCarcinoembryonic antigen
2009
Pancreatic Cyst Fluid Protein Expression Profiling for Discriminating Between Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm
Allen P, Qin L, Tang L, Klimstra D, Brennan M, Lokshin A. Pancreatic Cyst Fluid Protein Expression Profiling for Discriminating Between Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm. Annals Of Surgery 2009, 250: 754-760. PMID: 19806054, PMCID: PMC4556365, DOI: 10.1097/sla.0b013e3181bd7f20.Peer-Reviewed Original ResearchConceptsSerous cystadenomaProtein expressionMucinous cystsCyst fluid of patientsDifferential protein expressionIntraductal papillary mucinous neoplasmCyst fluidBenign serous cystadenomaPapillary mucinous neoplasmFluid of patientsNoninvasive IPMNOperative resectionMucinous neoplasmsPancreatic cancerUnsupervised cluster analysisIPMNBiomarker panelMain ductPatientsCystsCystadenomaResectionMultiplex assayDown-regulationOverall accuracy rate
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply